Skip to main content
Clinical Trials/ISRCTN45191339
ISRCTN45191339
Active, not recruiting
未知

IMIT P Ca – inviting men for prostate cancer screening using luminal index, bi-parametric and PSA density, to identify men with suspicious lesions and to evaluate acceptability

niversity College London0 sites800 target enrollmentMarch 10, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
niversity College London
Enrollment
800
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2023
End Date
December 1, 2025
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversity College London

Eligibility Criteria

Inclusion Criteria

  • 1\. Men aged 50\-75 years
  • 2\. No prior prostate cancer diagnosis/treatment
  • 3\. Willing and able to provide a written informed consent

Exclusion Criteria

  • 1\. Previous diagnosis of prostate cancer
  • 2\. Contraindication to MRI scan (contraindication for MRI scanning \[as assessed by the MRI safety questionnaire of the PET/MRI department] which includes but is not limited to: intracranial aneurysm clips or other metallic objects; intra\-orbital metal fragments that have not been removed; pacemakers or other implanted cardiac rhythm management devices and non\-MRI compatible heart valves; inner ear implants; and history of claustrophobia)
  • 3\. Men who require assisted living e.g. care home living
  • 4\. Lacks the capacity to consent

Outcomes

Primary Outcomes

Not specified

Similar Trials